Theragnostics was incorporated in the UK in 2015 with the aim of providing a portfolio of products to transform patient care in oncology through targeted molecular radiotherapy and molecular imaging diagnostic products.
The word Theragnostics is derived from Therapy and Diagnostics, and refers to the strategy of utilising radioactively labelled drugs. This allows us to take images of disease with one radioactive isotope for diagnostic and treatment planning purposes. It is then possible to treat the same disease by changing to a therapeutic radioactive isotope. This is the so called ‘treat what you see’ principle. Unlike conventional external beam radiotherapy the “Theragnostic” approach provides molecularly targeted delivery of radiation to cancer cells distributed throughout the body.
Theragnostics currently has offices in London, UK and Boston, USA and a clinical stage pipeline of agents addressing unmet clinical needs in several cancers.
Theragnostics was incorporated in the UK in 2015 with the aim of providing a portfolio of products to transform patient care in oncology through targeted molecular radiotherapy and molecular imaging diagnostic products.
The word Theragnostics is derived from Therapy and Diagnostics, and refers to the strategy of utilising radioactively labelled drugs. The allows us to image distribution with one radioactive isotope for diagnostic and treatment planning purposes prior to treatment of disease by a change of radioactive isotope to an appropriate therapeutic option. Unlike conventional external beam radiotherapy the “Theragnostic” approach provides molecularly targeted delivery of radiation to cancer cells.
Theragnostics currently has offices in London, UK and Boston, USA and a clinical stage pipeline of agents addressing unmet clinical needs in several cancers.
MISSION
To drive innovation in
the fight against cancer.
Enhancing patients' lives with precision
radiopharmaceuticals for personalized medicine.
VISION
To develop a complete portfolio of products to transform patient care, from initial diagnosis to therapy, including treatment planning and monitoring.
MISSION
VISION
To drive innovation in the fight against cancer. Enhancing patients' lives with precision radiopharmaceuticals for
personalized medicine.
To develop a complete portfolio of products to transform patient care, from initial diagnosis to therapy, including treatment planning and monitoring.
